antidepressant etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster
antidepressant etiketine sahip kayıtlar gösteriliyor. Tüm kayıtları göster

6 Mayıs 2017 Cumartesi

‘I don’t know who I am without it’: the truth about long-term antidepressant use

Sarah never planned to take antidepressants for 14 years. Three years after she began taking them, when she was 21, she went to her GP and asked to stop: 20mg of Seroxat a day had helped her live with anxiety and panic attacks, but she began to feel uncomfortable about being on medication all the time. Her doctor advised her to taper down her medication carefully.


At once, “I was a mess,” she says. “I thought I was losing my mind. My appetite completely went. I lost the best part of two stone. I was anxious constantly. My mouth was dry. It was difficult to sit and be calm.” She became withdrawn, refusing to see friends, and remembers asking her mother to get her a couple of boxes of paracetamol, thinking, “I’m going to have to take all these tablets, because I can’t live like this.”


Sarah’s doctor encouraged her to go back up to 20mg. “Within a week, I was much better. I feel anger when I look back. That wasn’t me relapsing, that was withdrawal. But I was so unwell, I didn’t stop to think, ‘I’ve never had this before.’ I truly thought it was me. Now the only reason I am on the drug is because I am dependent upon it. And that is not good enough.”


Prescriptions of SSRIs (selective serotonin reuptake inhibitors), the most common type of antidepressant, have doubled in the past decade. There are now more than 70m prescriptions dispensed in the UK in a year, the “greatest rise” of any drug in the last year, according to NHS research. But while the side-effects of starting and then withdrawing from these drugs are reasonably well known (the patient information leaflet accompanying the SSRI Seroxat is six pages long), there is very little research into the long-term effects of using antidepressants.


Last year, an all-party parliamentary group began hearing evidence as to whether there is a link between a measurable rise in mental health disability claims – 103% between 1995 and 2014 – and that in antidepressant prescriptions. (Claims for other conditions fell by 35% in the same period.) “We need to have a serious rethink about current levels of prescribing, because it may well be that the drugs are in fact contributing to the disability burden,” Dr Joanna Moncrieff, a consultant psychiatrist and senior lecturer at University College London, told the committee.


Reports both anecdotal and clinical have included side-effects such as constant pain, an altered sense of smell, taste or hearing, visual problems, burning hands and feet; food or drug intolerances and akathisia (the medical term for a deep inner restlessness). When a patient begins tapering down their dosage, these effects are generally ascribed to the drug leaving their system; if it is long after withdrawal is supposed to be over, however, patients are often disbelieved (according to the drug companies, withdrawal should take just two weeks for most people, though they acknowledge that for some it can be months).


Professor David Healy, director of the department of psychological medicine at Cardiff University and author of 22 books on psychopharmacology, believes that antidepressants are overprescribed. “If you go into your average doctor – if you’ve been off the drug for half a year or more – and you complain [of a range of symptoms] and say, ‘I think it’s caused by this pill I was on’, he or she would say, ‘It’s been out of your body for months. You’re neurotic, you’re depressed. All we need to do is put you on another pill.’”


GPs, Healy says, are “relying on your word, and if it’s a choice between believing what you say and relying on what drug companies say to them, they [tend to] believe the drug companies”. Healy, who has been a consultant for, and expert witness against, most of the major pharmaceutical companies, has long argued that long-term side-effects are routinely ignored or misunderstood.


But many experts believe these drugs do more good than harm. “Most of the people I see who have moderate to severe depression benefit from them,” says Daniel Smith, a professor of psychiatry and researcher into bipolar disorder at the University of Glasgow. For some, medication can be no less than “transformative. It can get them through a really critical period of their life.”


However, when it comes to long-term impact, especially after a person stops taking SSRIs,Smith says it can be hard to work out which symptoms relate to the drug use and which to the underlying conditions. “There’s obviously an issue of cause and effect. How can we be certain the SSRI caused it? Depression affects libido and sexual interest. How much [of the reported effects] is depression and/or anxiety symptoms coming back?”



A Seroxat box and pills


By 2003, worldwide sales of Seroxat, manufactured by GlaxoSmithKline, were worth £2.7bn. Photograph: Alamy

SSRIs have beenaround for more than 40 years, but grew in popularity in the late 1980s and 90s after pharmaceutical companyEli Lilly launched fluoxetine, otherwise known as Prozac. Time magazine put the drug on its cover twice, asking, “Is Freud finished?” and describing SSRIs as “mental health’s greatest success story”. In 2001, a landmark report on a clinical trial into paroxetine (sold as Seroxat in North America and Paxil in the UK), called Study 329, concluded that it demonstrated “remarkable efficacy and safety”. Study 329 led directly to a massive increase in prescriptions: by 2003, worldwide sales of Seroxat (manufactured by GlaxoSmithKline) were worth £2.7bn.


But concerns were raised about the study –the US food and drug administration (FDA) officer who reviewed the data disagreed with the findings, calling it a failed trial – and in 2015 the British Medical Journal published a re-evaluation. Seven authors went through as many of the thousands of individual case reports as they could, and found not only that “the efficacy of paroxetine… was not statistically or clinically different from placebo”, but that “there were clinically significant increases in harms, including suicidal ideation and behaviour”. The original study reported 265 adverse reactions; the BMJ found 481. The re-evaluation also found that psychiatric responses were grouped together with “dizziness” and “headaches”, rather than given their own category. In 2003, the UK banned the use of Seroxat by anyone under 18; and in 2004 the FDA required a “black box warning” on all antidepressants, its strictest level of patient warning.


“Patient safety is our number one priority,” a GlaxoSmithKline (GSK) spokesperson tells me. “We believe we acted responsibly in researching paroxetine, monitoring its safety once it was approved and updating its labelling as new information became available.”




It’s more reliably predictable that they’re going to get rid of sexual function than get rid of depression




Many SSRI users report blunted emotions, even long after they have ceased taking pills, and an impact on sexual function. “They should be called anti-sex drugs rather than antidepressant drugs,” says Jon Jureidini, a child psychiatrist of 30 years’ standing, a professor of psychiatry and paediatrics at the University of Adelaide and co-author of the BMJ study, “It’s more reliably predictable that they’re going to get rid of sexual function than it is that they’re going to get rid of depression.” Again, some people find this persists long after they cease taking the drug. One person I spoke to, Kevin, had taken Prozac for six months when he was 18; now 38, he hasn’t had an erection since.


Last September, Healy and colleagues published a further examination of the data gathered for Study 329. This data followed the trial participants for six months after they started taking paroxetine (the “continuation phase”) and while they were tapered off it. GSK, which in 2004 published a clinical study report, had argued that “the long-term safety profile of paroxetine in adolescents appears similar to that reported following short-term dosing”. Healy and co, however, concluded that the “continuation phase did not offer support for longer-term efficacy”. More alarmingly, they found that the taper phase, when patients were being taken off the drugs, was the riskiest of all, showing a “higher proportion of severe adverse events per week of exposure”. This, they said, opens up the risk of a “prescribing cascade”, whereby drug side-effects are thought to be symptoms, so are treated with further drugs, causing further side-effects and further prescriptions – thus increasing the risk of long-term prescription drug-dependency.


In October, the British Medical Association published its response to a two-year fact-finding exercise into long-term use of psychoactive drugs. It noted that while benzodiazepines, z-drugs, opioid and antidepressants are “a key therapeutic tool”, that their use can “often lead to a patient becoming dependent or suffering withdrawal symptoms… the evidence and insight presented to us by many charity and support groups… shows us that the ‘lived experience’ of patients using these medications is too often associated with devastating health and social harms”; it was therefore, the report concluded, a “significant public health issue”.


The BMA made three key recommendations: first, and most urgently, that the UK government establish a 24-hour helpline for prescribed drug dependence; second, that it establish well-resourced specialist support units; and third, that there should be clear guidance on prescription, tapering and withdrawal management (they found the current approach to antidepressants, in particular, to be inconsistent: too many patients were suffering “significant harm”). There are also increasingly urgent calls for studies into long-term effects that are not funded by drug companies, because, Moncrieff says: “We don’t have very much data. This research is really important, but hasn’t been done. It’s a massive blind spot. It’s extraordinary – or maybe, given the pressures and interests at work, not extraordinary at all – that it hasn’t been filled.”


In March this year, members of the BMA, along with MPs and researchers from Roehampton University, went to parliament to lobby Public Health England, armed with research estimating that there are 770,000 long-term users of antidepressants in England alone, at a cost of £44m to the NHS per year (a figure that does not account for the cost of GP appointments, or the impact of side-effects, withdrawal effects and disability payments).


“I think you have to adopt a very conservative approach,” says psychiatrist Jon Jureidini. “These are brain-altering drugs, and our overall experience with brain-altering drugs of all kinds is that they tend to have a detrimental effect on some proportion of people who take them long term. All we know about the benefits is from short-term symptom-reduction studies. The careful prescriber needs to say, ‘Well, in balancing the likely benefits and harms, I need to be very cautious about how much benefit I’m expecting, and I need to be very generous about the possibility that the harms might be more than they appear to be.’”


Quite a few long-term users, such as those I spoke to below (and who wished to be anonymous), would agree.


‘Tapering off is the hardest thing I’ve ever done’: Sarah, 32; has taken Seroxat for 14 years


I was prescribed Seroxat when I was 18, the year I started university. I grew up with a disabled sister, so things at home were very stressful, and I had a history of anxiety and panic attacks. I had counselling, but the problems persisted, so I went back to the GP. I don’t remember everything that was said, but there was no conversation about side-effects.


Within the first two weeks of starting Seroxat, I remember I was sitting in the front room watching TV when out of nowhere I had this intense feeling of heat, like an electric shock. It started in my hands, went all the way up my arms and through to my head.


The GP said it was probably just my body getting used to the drug. And after a few weeks the weird sensations did ease off. I had a fabulous time at university. I still had panic attacks, and there were certain situations I would avoid – as I still do – so it wasn’t a wonder drug, but there were no major problems.


But in 2006 I tried to come off it. There were a couple of Panorama documentaries about the side-effects and I was starting to become concerned. The GP said, “That’s fine, but do it gradually, over three weeks.”




I thought I was losing my mind. I was going to work, but it was difficult to get through the day. My mouth was so dry




I immediately became incredibly unwell. I thought I was losing my mind. I was going to work, but it was difficult to get through the day. My mouth was so dry, I was constantly drinking water. I had bizarre thoughts – not hallucinations – that were frightening or distressing. I had a strong sense of detachment from reality.


Eventually, the doctor said, “Look, you coming off is obviously not working: we need to get you back to 20mg.” Within a week I was much better.


A few years later, when I realised my mental health was getting worse, even though I was on the medication, I started to do some research, reading case studies about withdrawal. I find it so offensive when a GP says, “This is who you are.” I didn’t have these symptoms 10 years ago. I didn’t have this sense of detachment. I saw various psychiatrists. They just kept saying, “The drug is safe, you need to be on it.” A couple of others told me the reason I was having these problems was because I wasn’t taking enough. Another said, “If you were diabetic, you’d take insulin and you wouldn’t have an issue. Why are you so bothered about taking this drug?”


I’ve been on it since I was 18, so I don’t know who I am without it, as an adult. Who knows? I might have all kinds of problems, but I need to know I’ve tried. Tapering off is the hardest thing I’ve ever done. It’s taken me three years just to get from 20mg to 5mg. I’m no longer with my partner – we were together for six years. I believe Seroxat has played a part: it affected my moods, it made my anxiety worse and, by necessity, I’ve had to be selfish, really. I don’t want to say all my problems are to do with Seroxat, because they’re not. But I do believe that it has caused me harm.


‘I don’t have much of an interest in interacting romantically or physically with the opposite sex’: Jake, 24; took SSRIs for eight years


I had been dealing with symptoms of OCD and anxiety for a lot of my childhood. It’s in my family, affecting two siblings and one parent. I was prescribed Zoloft when I was 12; I took a variety of SSRIs, Zoloft to Prozac to Lexapro, and then two others, for eight years.


Did they help? You know, I can’t really tell you, because I got through school. I got high marks, I had a lot of friends. So, in that sense, they must have helped. That’s the thing: for people with major depression, it’s easy to say, this has a measurable effect. But I kept taking them just because that’s what I’ve always done.


I went to university right out of school. I did very poorly. I had a bit of a breakdown, isolating myself, not sleeping. I was still on medication. I came home and enrolled at a community college. That was my worst period – I was very depressed. And I started to think, “I’ve been on these medications a long time. I’m not doing well – why not get off them?” I don’t recommend this at all to anyone, but I stopped going to a psychiatrist and took myself off.



prozac


Prozac. Photograph: Getty Images

For months I had trouble sleeping. I was jittery. I had brain zaps. My anxiety was pretty ramped up. I would feel numbness in my extremities – generally my arms. My psychiatrist told me these were just normal withdrawal symptoms, and they’d be gone in four to six weeks: “Anything you feel beyond that is your anxiety and depression returning.” Basically, if you still feel anything beyond this window that the medical community has established, it’s all in your head.


Eventually I went back to school full-time, and I remember doing OK, feeling somewhat better.


I’ve now been drug-free for four years. What’s lasted are the sexual side-effects. They were definitely worse in withdrawal than they had been on the drug, even though I didn’t really realise or understand it at the time, primarily because I started to take SSRIs at 12. While my brother took the same medicine over the same period and had a normal sexual life, I had a lack of sexual interest. I had erections, and I have regularly masturbated my entire life. But I don’t have much of an interest in interacting romantically or physically with the opposite sex.


I didn’t even start thinking about sex until a couple of years ago. It’s almost like I woke up one day and thought, “OK!” I started getting these windows – days or weeks – when normal sexual feelings would appear. But they’re new to me and I don’t know what to do about them. And because I don’t know what to do, I get anxious, and the anxiety kills any feeling – and then I’m anxious because I’ve lost all my feeling.


Online, I’ve come across a big asexual community. Some also took antidepressants; I think there are a lot of people like me out there. I’d like to think that if I keep going to counselling and sleeping and eating properly, I can rectify these things.


In the end, it’s about pros and cons. If you’re lying in bed and can’t get up, is it better to function? If it was up to me, I’d say that, barring extreme circumstances, nobody under 18 should be prescribed these things. Your brain develops around them. Drug companies should be thinking of the long-term effect on people who can’t even consent.


‘If I missed a dose, I’d get shocks down the side of my body’: Chris, 43; has been taking Seroxat for 26 years


I was originally prescribed Seroxat for mild anxiety about my GCSEs. It was 1991, about the time GlaxoSmithKline released Seroxat. I was one of the first people to be given it.


I was prescribed 20mg, the basic dose, to start with. It helped me: I got through school, I went to uni, I went to work. But I had side-effects from the off: profuse sweating, low libido. I’m quite a placid person, but I became aggressive. I never suffered, in the beginning, with the suicidal thoughts that people talk about now, but what I did notice was that if I missed a dose – especially after eight years of taking it – I’d get shocks down the side of my body. I’d be nauseous, my limbs would become weak. I’d be in a constant state of confusion and was very impatient. I couldn’t communicate well with people. I said this to the doctor, and he said, “We’ll up the dose to 40mg.” That was 1998.




I tried to go back to 20mg, but my words became slurry, so the doctor put me back up to 60mg




The 10 years after that weren’t too bad. I managed to work, as a sales rep, for 18-20 years. But by 2012, by which time I was up to 60mg, I had tried on numerous occasions to withdraw. I tried to go back to 20mg, but my words became slurry, so the doctor put me back up to 60mg.


By the time I was 38, even that wasn’t enough. I tried to take my life. The doctor wouldn’t prescribe a higher dose. I couldn’t do my job, I couldn’t concentrate, I couldn’t drive. A psychiatrist once said to me that coming off Seroxat is harder than quitting heroin. That really hit home.


I have now been unable to work for four years. I’m still seeing a psychiatrist. I’ve also been diagnosed with fibromyalgia: constant tiredness, aches in the neck, and in the lower back and lower limbs. I’m 43 and still live with my mum and dad.


I also have no libido. Since the age of 30, I have had no feelings in that regard whatsoever. I have had relationships, but they’ve all failed. I haven’t been in a relationship for 10 years, which is a long time to go without sex, but I just don’t get the urge.


I don’t really have emotions, to tell you the truth. The drug takes your emotions away. I’m sort of existing, not living.


And when the drugs do work…


‘I wanted to be able to feel good when good things were happening, bad when bad things were happening’


BySimon Hattenstone


I suppose I was a depression snob. A purist. Why should I take antidepressants? Yes, there was something rubbish about crying all the time, not functioning, being unable to answer simple questions because of the fug in my head. But, hey, at least I was true to myself.


My depression went back to my late teens. I didn’t like to think of myself as depressive, because depressives were losers. And I didn’t think I fitted the bill: I was pretty funny and able, and I could get girlfriends. I guess most depressives don’t think they fit the bill.


It might have been genetic. My dad had paralysing depression, and so did his father. As a young boy, I’d spent three years off school with encephalitis – an inflammation of the brain that is often fatal. Survivors are often left with depression.


I remember as a teenager being on holiday in Greece with friends. The weather was gorgeous, and I thought, “Why can’t it piss down, because then at least I’d have a reason to feel this way?”


That is what I always craved – objectivity. To be able to feel good when good things were happening, to feel bad when bad things were happening. I hated the fact that my feelings rarely correlated to what was going on in my outer world.


In my 20s, I got by. I held down a good job, fell in love, had kids, made friends, had a pretty good life. But things came to a head when my best friend killed herself. I’d find myself weaving in between traffic wondering what the impact would be like. I took a period off work and gratefully accepted my Prozac prescription.


Things had changed since I first rejected them. Prozac looked cool (lovely green-and-white pills) and rock bands wrote great songs about it (even if REM’s Shiny Happy People was supposed to be dystopic). After telling people I was off work with depression, I ended up feeling like a priest at confessional. It turned out that virtually everybody I knew was a depressive and pilling their way out of it; now it was “our secret”.




I would try to come off the pills and felt rubbish again – not more rubbish than before, but the same. So I returned




Initially, Prozac made me feel sick. And then magically, after a couple of weeks, I felt lighter, as if something had been lifted. I could hear questions properly, answer logically, enjoy a sunny day.


My partner said I was transformed. Occasionally, I would try to come off the pills and felt rubbish again – not more rubbish than I had before, but the same. So I returned, and after a while, I thought, “What’s the point of even thinking about coming off the pills if they make life work for me?”


There are times now when I wonder if I weep and fret and withdraw too much, and whether I’m becoming immune to the Prozac. But on balance I think not, because life is still so much better than it was.


If Prozac was no longer working for me, would I stop taking it? Probably. Would I stop taking antidepressants full stop? I doubt it. I’d simply look for another super pill.


• Are you a long-term user of antidepressants? Tell us about your experiences


  • If you are affected by the issues raised in this piece, contact the Samaritans here.


‘I don’t know who I am without it’: the truth about long-term antidepressant use

15 Haziran 2014 Pazar

Antidepressant nation: is stress creating pill poppers of us all?

With broad-eyed enthusiasm I started out telling close friends who I knew were struggling how wonderful these tablets had been, urging them to get some too. It was then that I realised I was a little late to the celebration. Turned out it was previously very a bash. From the buddy who didn’t adore her husband but stayed for the youngsters, to the one with the nerve-racking profession, the single mother struggling to make ends meet and the colleague who had been on Prozac for 20 many years – all of a sudden it appeared as even though each female I knew was propping up her mental well being with pills. In a straw poll of ten fast female close friends, I identified eight of them had been taking or had taken antidepressants.


In which as soon as our coffee mornings had been all bitching about husbands and discussing strategies for the evening meal, they grew to become a kind of antidepressants drop-in clinic. None of us was judging any person – how could we? – but the scale of use astounded us all.


Was this a regional phenomenon? Was the town exactly where I lived facing an epidemic of middle-class misery? Apparently not. In accordance to the Well being &amp Social Care Data Centre, prescriptions for antidepressants stood at about 28 million in Britain in 2003. By 2012 the figure was 50 million. Meanwhile, a survey by the charity Platform 51 discovered a single in three British ladies had utilised antidepressants. (Figures for men are tougher to come by, but anecdotally they are nearer 1 in 10.) So it wasn’t just me and my friends.


Why then? What was taking place that we felt we essential pharmaceuticals just to get through the day? The causes were a lot of, but underlying everyone’s story was a sense that daily life hadn’t turned out how we had expected. There was a disconnect between our expectations and the actuality of our everyday grind.


Emma, a nurse and mother of two, felt the stress soon after obtaining her first youngster: “I imagined there was a proper way to do issues and if I didn’t do it that way then I would mess up my kid’s daily life permanently. I gave myself no room for error. When my daughter couldn’t breast-feed I felt like a failure. I believed that was motherhood, and daily life would be misery from there on. Taking antidepressants lifted a veil.”


Buddies with out youngsters were also buckling. Sophia, a civil servant in London, discovered herself unable to get out of bed a single morning: “I’d been doing work prolonged hrs, holding down this huge crucial work, hunting to all the planet like a high-flyer, whilst trying to manage quite a destructive romantic relationship at home. I just imploded. I couldn’t end crying. Antidepressants produced me feel the happiest I’ve ever been. I fret because now I’m attempting for a infant and I’m not sure I need to stay on them, but I genuinely do not ever want to stop.”


Certainly it’s not information that today’s girls are facing enormous pressures: to have a brilliant occupation, a meaningful romantic relationship and excellent children, whilst curating a capsule wardrobe, saving the planet and doing naked yoga. The complicated issue, says Cosmo Hallström, a advisor psychiatrist and a fellow of the Royal College of Psychiatrists, is that daily life – on the surface at least – is greater than ever for most of us. “Services are much better, education is better, we have cozy properties and lots of entertainment,” he says. “But, as the regular of residing has accelerated, our expectations have grown. We are bombarded with messages about how wonderful life ought to be and truly feel like failures when factors really don’t turn out like that.”


But then haven’t there constantly been pressures, as any loved ones gathering involving a grandparent or two tends to propose? Our contemporary woes, with their emphasis on unrelenting happiness and private fulfilment, look rather vain and self-obsessed in contrast with those of women in the past. Have we merely lost our backbone? Are we a generation so cosseted that we’re no longer ready to cope with standard human trials and tribulations?


As my late grandmother always appeared to take pleasure in telling me, “Nobody mentioned it was straightforward.” While the notion of mother’s little helpers is nothing new – our mothers had Valium, their mothers gin and reduced expectations – when you are confronted with the substantial actuality of it, when practically each and every female you know is on antidepressants, that is very a massive deal, is not it? You can’t assist asking yourself whether or not we’re taking them because we actually need to have to or just simply because we can. Are we like children who, getting opened a forbidden packet of biscuits, gorge away right up until a grown-up stops them or right up until they make themselves sick? Does the biscuit tin require to be positioned on a increased shelf?


The Council for Evidence-primarily based Psychiatry (CEP) undoubtedly thinks so. The CEP is a body of top medics, psychiatrists and academics who have come collectively to deliver a collective wake-up contact, highlighting what they say are the potentially hazardous results of antidepressants and the “medical model” for treating psychological-well being disorders.


Dr James Davies, a psychotherapist and a co-founder of the CEP, thinks that as a society we are progressively lowering the bar on what constitutes psychological illness. “More and far more of our normal, normal, albeit painful experiences are getting wrongly classified as psychiatric situations – all of which leads to more prescriptions for strong psychotropic medicines,” he says.


The comedienne and mental-health campaigner Ruby Wax, whose very own battle with depression has been nicely documented, has characteristically powerful views on the topic. As she puts it, “We’re all going to the doctors saying, ‘Mummy, correct me,’ when we should be taking charge of our personal minds, obtaining out how the machine works.”


Wax argues that we have misplaced many of the local community connections that employed to aid us deal naturally with reduced mood – locations this kind of as church, and chats more than the garden fence – and have become as well reliant on GPs for our salvation. In her manifesto for mental overall health, Sane New Planet: Taming the Thoughts, she suggests drop-in centres the place folks can share their experiences, as happens at Alcoholics Anonymous meetings, and accessibility talking therapies this kind of as mindfulness and cognitive behavioural treatment (CBT). “How did they [AA] organise these get-togethers so nicely? They have meeting locations on every corner – much more than there are Starbucks – and these individuals are drunks!”


It’s a brilliant thought – I for one particular would be a normal at my local centre – but it would almost certainly need the kind of investment from government that is not going to take place any time quickly. Nevertheless, “talking therapies” along the lines of CBT and mindfulness-based mostly cognitive therapy (MBCT) are more and more getting observed as credible options to prescription medication: my local wellness authority in Dorset, for instance, has recently launched its own talking-therapies scheme, allowing patients to self-refer with no very first obtaining to seek advice from their GP. Though slightly different in their strategy, CBT and MBCT function on equivalent principles: encouraging an understanding of how our thoughts, emotions and behaviours interact and a emphasis on the present. The thought is that greater awareness of our feelings and considering helps us deal with rather than feel overwhelmed by them. (You can get began on MBCT on your personal with a book this kind of as Mindfulness: A Useful Guidebook to Obtaining Peace in a Frantic World by Prof Mark Williams and Dr Danny Penman.)


For Fran, a 45-12 months-old self-employed mom who has taken antidepressants in the previous, CBT sessions offer you the perfect thoughts-maintenance regime: “I really feel happier realizing I’m finding out the tools to deal with my nervousness naturally. It’s like carrying out yoga or Pilates for the mind. The pills numbed me to the encounter totally, whereas CBT assists me put issues into viewpoint by myself.” But access to these therapies is patchy at best. Waiting times vary in between regional authorities and can be something from a fortnight to a yr – and even two weeks can appear like a lifetime when you are feeling minimal.


Jim Woods, a GP primarily based in Devon, says that the lengthy wait for counselling appointments is sometimes the purpose why he prescribes antidepressants. “You get a holistic view and speak about how they can enhance items,” he tells me. “But you also want to help, and there is typically a long wait for CBT and counselling. If they want aid and you can’t prescribe some thing that will function instantly, then you are not actually helping. And antidepressants do operate.”


Just how protected the pills are and managing daily life right after them are the other elephants in the doctor’s waiting-room. Google “side effects of antidepressants” at your peril – or only if you are on a very higher dose of them and for that reason couldn’t care what you learn – since the stories of collateral harm can appear terrifying: reduction of libido and sexual function, headaches, memory reduction, dizziness, insomnia, issues urinating… Prolonged use has also been linked to sort-two diabetes and, in excessive instances, suicidal ideas.


Prof Jonathan Haidt, an American social psychologist, TED Talks poster-boy and the writer of The Happiness Hypothesis, says that we come to feel unpleasant and tend to moralise when individuals try out to boost their great deal, specifically if they do so with “short cuts” such as pills. But, he adds, that doesn’t indicate it is wrong for them to consider. “I feel it’s misguided and intolerant to insist that every person need to only accomplish personal modifications by means of challenging function, and not by means of some thing as basic as a pill. Several individuals find SSRIs assist them be the particular person they constantly wished to be and want they’d found them 20 many years earlier.”


It is a dizzying image. The rights and wrongs, the causes and cures – they are almost adequate to make any person truly feel depressed. What is crystal clear is that numerous females genuinely come to feel unable to cope with the predicament in which they locate themselves. And although we would welcome far more treatment and counselling, in a time of mental crisis we’ll take what ever we can get our hands on when such options are not immediately accessible.


As for me, I’m off antidepressants now, navigating daily life fairly anxiousness-cost-free. Medicine restored my cheery disposition, but it also manufactured me truly feel weirdly numb. I missed emotional contrast, the light and shade of life, which had been eclipsed by the dazzle of artificial sunshine. So I’m undertaking all the boring factors, currently being more mindful and going gently by means of existence. And it feels Okay.


To read a lot more posts from Stella Magazine, visit telegraph.co.uk/stella


Adhere to @StellaMagazine on Twitter


Comply with us on Facebook for much more stories


Comply with Sarah Thompson’s blog at youresomummy.com, and on Twitter @youresomummy



Antidepressant nation: is stress creating pill poppers of us all?

28 Mayıs 2014 Çarşamba

Surge in antidepressant use following financial crisis


The variety of men and women utilizing antidepressants rose significantly during the financial crisis, with an extra 12.5 million drugs prescribed in 2012 compared to five many years earlier, a research has located.




Nick Barber, director of analysis at the Overall health Basis, told The Guardian that the report, published on Wednesday, was the “most exact and insightful research of medication in this region in this country” and questioned the way in which individuals have been currently being treated.




He explained: “The price of boost in prescribing had been nonetheless for some years and does seem to be to have enhanced from 2008 so it would propose that recession and some of the related issues such as unemployment could be part of it.


“If depression has increased as well as the prescribing the query is: ‘Is it being treated effectively?’


“There’s also an financial question at the time of recession as to whether or not we’re using our medication assets as well as we could be.”


The value of living throughout the economic downturn is also considered to be a factor in the surge in prescriptions.


The report says a rise in unemployment and the cost of residing throughout the crisis “could have an effect on the prevalence of mental overall health problems”.


The United kingdom has the seventh highest prescribing charge for antidepressants in the Western world, with around four million Britons taking them each and every 12 months – twice as many as a decade in the past.




Surge in antidepressant use following financial crisis

27 Mayıs 2014 Salı

Antidepressant use soared during recession in England, study finds

The use of antidepressants rose significantly in England during the financial crisis and subsequent recession, with 12.5m more pills prescribed in 2012 than in 2007, a study has found.


Researchers from the Nuffield Trust and the Health Foundation identified a long-term trend of increasing prescription of antidepressants, rising from 15m items in 1998 to 40m in 2012. But the yearly rate of increase accelerated during the banking crisis and recession to 8.5%, compared to 6.7% before it.


The report also found that rises in unemployment were associated with significant increases in the number of antidepressants dispensed and that areas with poor housing tended to see significantly higher antidepressant use.


Nick Barber, director of research at the Health Foundation, said that the report, published on Wednesday, was the “most accurate and insightful study of medication in this area in this country” and raised questions about whether people were being treated appropriately.


“The rate of increase in prescribing had been still for some years and does seem to have increased from 2008 so it would suggest that recession and some of the associated problems such as unemployment could be part of it,” he said. “If depression has increased as well as the prescribing the question is: ‘Is it being treated properly?’ There’s also an economic question at the time of recession as to whether we’re using our medicine resources as well as we could be.”


The report says a rise in unemployment and in the cost of living during the recession “could have an impact on the prevalence of mental health problems and require changes in the service delivered”, although it does not specify what those changes should be.


The increase in prescribing was despite the coalition government providing extra funding for the Improving Access to Psychological Therapies (IAPT) programme, introduced by Labour in 2008 to help people in distress access talking therapies. “The question is whether that is just because it’s a relatively young service or whether it reflects that there are delays [in accessing IAPT],” said Barber. “If you’re a prescribing GP with a distressed patient, if you know there’s a delay in this service, I am sure you will be more likely to prescribe antidepressants.”


An NHS report published in January found that while GPs made 883,968 referrals for psychological support in England in 2012-13, only 49% of them led to someone suffering from mental health problems starting treatment.


The Focus on Antidepressants prescribing report, part of the Nuffield Trust and Health Foundation’s QualityWatch programme, which is tracking the quality of health and social care in England, found that over the 14 years covered by the report, the increase in prescription of antidepressants outstripped the rise in depression.


Dr Cosmo Hallström, a fellow at the Royal College of Psychiatrists, said that while the figures were likely to raise concern in some quarters about over-prescription of antidepressants, he saw their increased use as a positive development on the whole, reflecting increased awareness of depression and how to treat it. “There needs to be a spectrum of treatments available,” he said. “Whereas antidepressants won’t be the best treatment in all cases they are of proven benefit and shouldn’t be denied to people who are waiting for something else.”


But he cautioned that they should not just be prescribed without follow-up. “You should review over a few weeks to see whether they are really working or not,” he said.


The researchers also observed wide variation in prescriptions between areas and different GP practices. For example, Blackpool residents were prescribed more than four times as many of the tablets each month per 1,000 people as Brent, in north London.


The report found that areas with more white people, more women, and more people over the age of 65 had the heaviest use of antidepressants, while GPs who prescribed more antibiotics also tended to prescribe more antidepressants, which Barber said “confirmed that some doctors are more inclined to reach for the prescription pad”.


London had a lower level of prescribing, which the authors put down to its younger and more ethnically diverse population, while the north-east, which has high rates of unemployment, had higher levels.


Adam Roberts, senior research analyst at the Nuffield Trust, who was one of the report’s authors, said: “The variation isn’t explained by rates of depression, which is what you would think. Someone with more expertise should look at defining what the appropriate rate is and how the variation is explained. We tried to explain it to a certain extent but we couldn’t fully explain it.”


The authors have created a modelling spreadsheet for GPs and clinical commissioning groups to calculate their expected level of prescribing of antidepressants, based on factors such as the profile of patients in their area and socioeconomic indicators, and compare that with their actual prescriptions.


Researchers also discovered that a 1% rise in unemployment over time typically meant one and a half more tablets were given out per person on a GP list per year. By contrast, comparing practices in different geographical areas, rather than analysing trends over time, did not show clear links to unemployment, although areas with worse housing tended to see significantly higher antidepressant use.



Antidepressant use soared during recession in England, study finds

Rise in antidepressant prescriptions rates in England: get the data

The amount of antidepressants dispensed annually in England rose by 25m between 1998 and 2012– from 15m items in 1998, to 40m in 2012 – according to a new study which claims that England’s increasing use of antidepressants has accelerated since the financial crash in 2008.


Published as part of the Nuffield Trust and Health Foundation’s QualityWatch programme, the research shows that almost half of the increase between 1998 and 2012 occurred in the four years between the 2008 financial crisis and 2012 (the last year for which data is available). Meaning the annual rise in prescriptions has risen to 8.5% per year since the banking crash, compared to 6.7% before.


The release notes:



This striking increase is despite the incidence of depression having risen much more slowly over the same time period, meaning that either antidepressants were heavily under-prescribed in 1998, or they are heavily overprescribed now.


Some GP practices also prescribed far more antidepressant medicine than others even where their patients were similar – suggesting over-use or under-use in many parts of England.



Researchers also found that even when regional characteristics are taken into account, large geographical variations in the rate of prescribing exist – echoing research carried out in 2011 by the Guardian which revealed a north-south divide in the prescription of antidepressants.


This latest report – examining the number of tablets dispensed on NHS prescriptions across the country – shows that between October and December 2012/13, rates varied from 71 items per 1,000 people in NHS Brent, to 331 items per 1,000 people in NHS Blackpool.


They also found that generally, there were higher rates of prescribing in the north-east and lower levels in London. The map below shows antidepressant prescription rates per 1,000 people by primary care trusts (PCTs) in England.


Other key findings from the report are:



  • Areas with more white people, more women, and more people over the age of 65, had the heaviest use of antidepressants

  • Areas with more men and more people from ethnic minorities, had significantly lighter use


  • GPs who prescribe more antibiotics also tend to prescribe more antidepressants, suggesting doctors vary across the board in how likely they are to use drugs to deal with their patients’ conditions.

  • An analysis of changes over time found that increases in unemployment were associated with significant increases in the number of anti-depressant tablets dispensed. A 1% rise in unemployment typically meant one and a half more tablets were given out per person on a GP list, per year


The table below shows figures obtained from the Health and Social Care Information Centre (HSCIC) by the Nuffield Trust and the Health Foundation. They show the number of antidepressant drugs prescribed by PCTs in England. The downloadable spreadsheet also has data on the trend in prescribing of antidepressants in England.


Download the data


• DATA: download the full spreadsheet


More open data


Data journalism and data visualisations from the Guardian


Development and aid data


• Search the world’s global development data with our gateway


Can you do more with this data?


• Contact us at data@theguardian.com
• Follow us on Twitter
• Like us on Facebook



Rise in antidepressant prescriptions rates in England: get the data